Ranitidine Market Observes Tremendous Rise in Revenue US$ 485.4 Million by 2026
![]() |
| Ranitidine |
Ranitidine is a member of the class
of medications known as histamine-2 blockers.
It reduces the amount of stomach acid production.
It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and
other conditions that cause the stomach and intestines to create too much acid,
including ulcers and recurrence. Additionally, indigestion, heartburn,
coughing, and stomach pain are also symptoms that can be treated with
ranitidine.
According To Coherent Market Insights, The Global Ranitidine Market Size Was Valued At US$ 412.4 Mn In 2017, And Is Expected To Witness A CAGR Of 1.8% Over The Forecast Period (2018 – 2026).
Global population growth and dietary changes are having a big impact on the Ranitidine Market, which is predicted to continue to grow during the forecast period. According to studies conducted by scientists at Scimed Central in 2017, 13-25% of people in western countries and 21-37% of people overall experience heartburn at least once each week. The Digestive Disease Center claims that alcohol, spicy food, coffee and other caffeinated beverages, peppermint, and tomatoes are among the foods and beverages that cause heartburn. Heartburn is brought on by overindulging in the aforementioned food and alcohol. The side effects of ranitidine are a significant barrier to the global market for the drug. Ranitidine has major adverse effects, such as a strong headache, fatigue, sleep issues, nausea, vomiting, stomach pain, diarrhoea, and stomach cancer.
The global Ranitidine Market is divided by application type into Zollinger Ellison syndrome, GERD, erosive esophagitis, stomach and intestinal ulcers, and others. The term "gastric ulcer" refers to painful ulcers on the stomach lining. This particular peptic ulcer condition. The only ulcers that can harm the stomach and intestines are peptic ulcers. A burning sensation in the chest or throat is known as heartburn. When stomach acid backs up into the oesophagus, it happens. As a result, GERD keeps occurring.
Top Companies involved are GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Strides Pharma Science Limited (StridesShasun), Tocris Bioscience (R & D Systems), Merck KGaA, and Sun Pharmaceutical Industries Limited among others.

Comments
Post a Comment